Stay updated on Taletrectinib ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.

Latest updates to the Taletrectinib ROS1+ NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe history now shows an added Revision: v3.3.2 and a removed Revision: v3.2.0, reflecting minor metadata updates to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoval of a government funding/operating-status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check42 days agoChange DetectedA new version entry has been added to the record history, reflecting an updated Study Status and related fields (e.g., Sponsor/Collaborators, Oversight).SummaryDifference0.1%

- Check56 days agoChange DetectedThe page changes remove the old recruitment status and date (Recruiting, 2024-11-21) and replace them with an updated recruitment status (Active, not recruiting) and updated date stamps (2025-10-16 and 2025-10-14) along with expanded section headers. Interpreting this, the study is currently active but not recruiting participants, and there are new or reorganized sections for study headers and contacts.SummaryDifference4%

- Check71 days agoChange DetectedAdded a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference12%

- Check78 days agoChange DetectedThe page now shows revision v3.1.0, replacing v3.0.2.SummaryDifference0.3%

Stay in the know with updates to Taletrectinib ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.